Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 23, 2024
Dynamic changes in <i>TP53</i> mutated circulating tumor DNA predicts outcome of patients with high-grade ovarian carcinomasMaria Kfoury, Clément Bonnet, Nicolas Delanoy, et al.
British Journal of Cancer|January 4, 2024
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancerLaura Mezquita, Marianne Oulhen, Agathe Aberlenc, et al.
British Journal of Cancer|February 8, 2022
Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinomaSusanne Flach, Karen Howarth, Sophie Hackinger, et al.
Frontiers in Oncology|April 14, 2022
Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung CancerBrendan Knapp, Laura Mezquita, Siddhartha Devarakonda, et al.
Plos One|June 12, 2020
Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assayJordi Remon, Aurelie Swalduz, David Planchard, et al.
NPJ Precision Oncology|February 3, 2026
Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patientsSusanne Flach, Christodoulos Pipinikas, Tom Huberty, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2020
Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAF<sup>V600E</sup> non-small cell lung cancerFrancesco Facchinetti, Ludovic Lacroix, Laura Mezquita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2026
Detecting ctDNA Using Personalized Structural Variants to Forecast Recurrence in Localized Soft Tissue SarcomaChangsu L Park, Elizabeth G Demicco, Karen Howarth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast CancerMarla Lipsyc-Sharf, Elza C de Bruin, Katheryn Santos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 18, 2019
Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System ProgressionMihaela Aldea, Lizza Hendriks, Laura Mezquita, et al.
Pageof 2